Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer

Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer

(2012) Suk-Joon Chang et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma

(2011) P.A. Cascales et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Antitumour Efficacy of Two Paclitaxel Formulations for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in an In Vivo Rat Model

(2011) Wim Bouquet et al.   PHARMACEUTICAL RESEARCH

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer

(2010) M. Deraco et al.   EJSO

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience

(2010) Michele Peiretti et al.   GYNECOLOGIC ONCOLOGY

The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm

(2010) Robert E. Bristow et al.   GYNECOLOGIC ONCOLOGY

Influence of Department Volume on Survival for Ovarian Cancer

(2010) Christian Marth et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Intraepithelial T cells and tumor proliferation

(2009) Sarah F. Adams et al.   CANCER

The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer

(2009) Francisco C. Muñoz-Casares et al.   Clinical & Translational Oncology

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer

(2009) Paul H Sugarbaker   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

(2009) Terence C. Chua et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

The Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

(2009) C. W. Helm   ONCOLOGIST

Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review

(2008) Andreas du Bois et al.   GYNECOLOGIC ONCOLOGY